| 000 | 01626 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513090628.0 | ||
| 264 | 0 | _c19960625 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1046/j.1471-4159.1996.66041592.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, C P | |
| 245 | 0 | 0 |
_aPresynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cApr 1996 |
||
| 300 |
_a1592-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAlzheimer Disease _xchemically induced |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBehavior _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xchemistry |
| 650 | 0 | 4 |
_aReceptors, Presynaptic _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xanalysis |
| 650 | 0 | 4 | _aResidence Characteristics |
| 650 | 0 | 4 |
_aSerotonin _xanalysis |
| 700 | 1 | _aAlder, J T | |
| 700 | 1 | _aBowen, D M | |
| 700 | 1 | _aEsiri, M M | |
| 700 | 1 | _aMcDonald, B | |
| 700 | 1 | _aHope, T | |
| 700 | 1 | _aJobst, K A | |
| 700 | 1 | _aFrancis, P T | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 66 _gno. 4 _gp. 1592-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.1996.66041592.x _zAvailable from publisher's website |
| 999 |
_c8626361 _d8626361 |
||